ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

July 11, 1975

Jackson Lab Should Be Rebuilt With Federal Funds, Panel Says

September 29, 1989

UICC Merit Award Winners Announced

September 19, 1986

CTAC Discussion, Group Chairs Comment

December 17, 2010

In Brief: OSCC Staff Appointments Announced Report Available On Chemical Disposal Health Aspects

August 3, 1984